Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (10)

1

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Torrico, F. | Gascón, J. | Ortiz, L. | +11

2

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis : a multicentre, single-arm, open-label, phase 2-3 trial

enthalten in: The Lancet. Global health | 2022

von Kande Betu Kumesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +20

3

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program

enthalten in: The American journal of tropical medicine and hygiene | 2022

von Valverde Mordt, O. | Tarral, A. | Strub-Wourgaft, N.

4

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA) : a phase 2, double-blind, randomised trial

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Gascón, J. | Barreira, F. | +34

CommentIn: Lancet Infect Dis. 2021 Aug;21(8):1057-1058. - PMID 33836159

5

Benznidazole in Chagas disease study : do the data justify progression to phase 3? - Authors' reply

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Barreira, F. | Strub-Wourgaft, N. | +2

CommentOn: Lancet Infect Dis. 2021 Aug;21(8):1129-1140. - PMID 33836161

6

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis : a prospective, multicentre, open-label, cohort study

enthalten in: The Lancet. Global health | 2021

von Kande Betu Ku Mesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +21

7

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens : a proof-of-concept, randomised, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Torrico, F. | Gascon, J. | Ortiz, L. | +52

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):363-365. - PMID 29352705

8

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis : a pivotal multicentre, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2018

von Mesu, V. | Kalonji, W. | Bardonneau, C. | +23

ErratumIn: Lancet. 2018 Jan 13;391(10116):124. - PMID 29129438

9

Improving the Quality of Host Country Ethical Oversight of International Research : The Use of a Collaborative 'Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis

enthalten in: Developing world bioethics | 2015

von Coleman, C. | Ardiot, C. | Blesson, S. | +23

10

Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis : first-in-human studies

enthalten in: Clinical pharmacokinetics | 2014

von Tarral, A. | Blesson, S. | Mordt, O. | +8

1
[1]